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Abstract
Background: Diagnostic accuracy might be improved by algorithms that searched patients’ clinical notes in the
electronic health record (EHR) for signs and symptoms of diseases such as multiple sclerosis (MS). The focus this
study was to determine if patients with MS could be identified from their clinical notes prior to the initial
recognition by their healthcare providers.
Methods: An MS-enriched cohort of patients with well-established MS (n = 165) and controls (n = 545), was generated
from the adult outpatient clinic. A random sample cohort was generated from randomly selected patients (n = 2289)
from the same adult outpatient clinic, some of whom had MS (n = 16). Patients’ notes were extracted from the data
warehouse and signs and symptoms mapped to UMLS terms using MedLEE. Approximately 1000 MS-related terms
occurred significantly more frequently in MS patients’ notes than controls’. Synonymous terms were manually clustered
into 50 buckets and used as classification features. Patients were classified as MS or not using Naïve Bayes classification.
Results: Classification of patients known to have MS using notes of the MS-enriched cohort entered after the initial
ICD9[MS] code yielded an ROC AUC, sensitivity, and specificity of 0.90 [0.87-0.93], 0.75[0.66-0.82], and 0.91 [0.87-0.93],
respectively. Similar classification accuracy was achieved using the notes from the random sample cohort. Classification
of patients not yet known to have MS using notes of the MS-enriched cohort entered before the initial ICD9[MS]
documentation identified 40% [23–59%] as having MS. Manual review of the EHR of 45 patients of the random sample
cohort classified as having MS but lacking an ICD9[MS] code identified four who might have unrecognized MS.
Conclusions: Diagnostic accuracy might be improved by mining patients’ clinical notes for signs and symptoms of
specific diseases using NLP. Using this approach, we identified patients with MS early in the course of their disease
which could potentially shorten the time to diagnosis. This approach could also be applied to other diseases
often missed by primary care providers such as cancer. Whether implementing computerized diagnostic support
ultimately shortens the time from earliest symptoms to formal recognition of the disease remains to be seen.
Keywords: Early Diagnosis [E01.390], Diagnostic errors [E01.354], Diagnosis, Computer-assisted [E01.158], Electronic
health records [E05.318.308.940.968.249.500], Natural language processing [L01.224.050.375.580], multiple sclerosis
[C10.114.375.500]
Background
Accurate and timely medical diagnosis is the sine qua non
for optimal medical care. Unfortunately, diagnostic error,
which includes delayed, incorrect or missed diagnosis, is
common and accounts for a significant proportion of med-
ical error [1, 2]. Studies looking at a variety of sources such
as malpractice claims, autopsy studies and manual review
of patients’ notes have revealed that misdiagnoses of disease
as a common problem that leads to harm including death.
Frequent errors include failure to order or interpret a test,
follow-up on finding an abnormal test result or complete a
proper history or physical exam [3, 4]. In the outpatient set-
ting, the overall missed diagnosis rate has been estimated
to be 5% [5, 6] and has been reported to be as high as 20%
for various cancers [7] and chronic kidney disease [8].
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Primary care providers, who are usually first to see
patients with medical complaints, are well aware that a
root cause of diagnostic error is inadequate knowledge
and failure to consider a diagnosis [9–13]. They cannot
be expected to have mastered the signs and symptoms
of the literally thousands of conditions, many belonging
to a rarified domain of specialists. With the sustained
exponential growth of medical knowledge, accurate
diagnosis of patients’ conditions seems increasingly un-
achievable without assistance from computerized diag-
nostic support [14].
There are several diagnostic tools such as Isabel®
(Isabel Healthcare Inc., USA), Watson® (IBM, Inc.
USA), and DxPlain® (Massachusetts General Hospital,
Laboratory of Computer Science, Boston, MS) that re-
turn a differential diagnosis based on signs, symptoms
and demographic information entered by the provider.
Although these tools have been shown to improve
diagnosis [15–18] they are underutilized for a variety
of reasons including the necessity of actively entering
data and lack of integration into the EHR [19, 20].
A diagnostic tool that raises awareness of a specific
disease could be integrated into the EHR. Illnesses char-
acterized by abnormalities in structured data, easily ac-
cessible to a computer, such as laboratory values or vital
signs, could be directly diagnosed by mining the patient’s
data. Some examples include identification of patients
with chronic kidney disease [21, 22], acute kidney injury
[23, 24], anemia [25] and sepsis [26].
Many diseases, however, are not characterized by ab-
normalities manifested in routine laboratory tests.
Consider neurological diseases, such as dementia, mul-
tiple sclerosis, myasthenia gravis or Parkinson’s disease,
or cancer, such as pancreatic or ovarian, illnesses char-
acterized in their earliest stages by subtle signs and
symptoms [27–30]. Implementing a diagnostic assistant
to achieve early identification of patients with these ill-
nesses is far more challenging because the computer
would have to “read” the unstructured narrative portion
of the medical record to identify the signs and symp-
toms characteristic of the particular disease using nat-
ural language processing (NLP). Based on the presence
or absence of these signs and symptoms, an algorithm
could provide an estimate of the likelihood that the pa-
tient had the illness in question.
The goal of this study was to test the hypothesis that
patients with diseases characterized by subtle signs and
symptoms could be identified early in the course of their
illness using NLP of the narrative portion of the clinical
notes in the EHR. We chose multiple sclerosis (MS) to
explore this hypothesis because a formal diagnosis of
MS is commonly missed [31] or delayed [32, 33] placing
the patient at risk for irreversible complications. Early
diagnosis is the key to treatment success [34, 35].
Methods
Study population
The patients whose notes were used for this IRB-
approved study attend the Associates in Internal Medi-
cine (AIM) clinic at Columbia University Medical Center
(CUMC). The clinic is staffed by 150 medical residents
and attending faculty who care for approximately 40,000
patients. Two patient cohorts were established for this
study: an MS-enriched cohort consisted of patients with
well-established MS and randomly selected controls (see
Table 1). We used the presence (or absence) one or
more ICD9 codes for MS (ICD9[MS]), “340”, as the gold
standard for the presence (or absence) of MS. The MS-
enriched cohort was used to identify predictive attributes,
develop a classification model and determine achievability
of early recognition. A Random sample cohort consisted
of randomly selected patients from the AIM clinic, some
of whom had MS. This cohort was used to identify
patients who might have unrecognized MS. Only those
MS and controls patients with clinical notes spanning
at least two consecutive years in their record were in-
cluded in the study.
Extraction and mapping of MS-related signs and symptoms
from clinical notes
Classification models were developed using attributes
(features) consisting of the well-known signs and symp-
toms of MS (terms), extracted from patients’ free-text
clinical notes using MedLEE, a natural language process-
ing tool that recognizes terms and maps them to the
United Medical Language System (UMLS) concept
unique identifiers (CUIs) [36]. The patients’ EHR notes
were sourced from the clinical data warehouse of CUMC
of the New York Presbyterian (NYP) system.
We gathered two collections (sets) of notes from the
MS-enriched cohort based on the timing of the notes in
relation to the date of the first entry of an ICD9[MS],
(see Fig. 1). The post-ICD9[MS] set were notes written
about the patients with MS two or more years after the
initial entry of an ICD9 code for MS (ICD9[MS]) into
the EHR, when the diagnosis was clearly established.
The pre-ICD9[MS] set were notes on these same patients
written prior to the initial entry of an ICD9[MS] code.
Notes of the control patients were entered up to two
years prior to the most recent note in the EHR. The
Table 1 Two cohorts used for MS classification study
Cohort Purpose Unique Patients
MS-enriched Identify predictive attributes,
develop a classification model,
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Random sample set were notes entered up to two years
before the last entry in the EHR in patients of the Ran-
dom Sample cohort (see Fig. 1).
Classification
We trained a classifier to distinguish patients with
known MS from those without MS, using the presence
or absence of MS-related terms in patients’ notes. We
used the Naïve Bayes classification algorithm from the
Weka suite to distinguish patients with MS from those
without, having previously determined that this algo-
rithm yielded the best results [10]. We assessed classifi-
cation accuracy by the receiver operating characteristics
area under the curve (ROC AUC), sensitivity and specifi-
city and 95% confidence intervals.
Results
Characteristics of MS patients and control cohorts
The average age of MS patients in the MS-enriched
cohort was 47.3 (SD 15.0), significantly lower than con-
trols 54.1 (SD 16.6) (p < 0.001). Of the MS patients,
85.1% were female compared to 68.7% of the controls
(p < 0.001). Both age and gender were subsequently
used as attributes in classification.
Attribute (feature) selection
The first step in building an MS classifier was to identify
terms in the patients’ notes that communicated MS
(such as “paresis” or “numbness”) that should be more
prevalent in patients with MS compared to controls.
From the post-ICD9[MS] set of notes of the MS-enriched
cohort unique terms were extracted of which 1,057 were
significantly more frequent in MS patients than in con-
trols (Chi-squared analysis and an odds ratio at 5% sig-
nificance level). Examples of terms with high odds ratios
(CI) relating to MS symptoms include weakness in legs,
38.8 (2.3, 693.4), orbital pain 34.9 (2.0, 614.3) and
paresthesia foot 38.8 (2.3, 693.4).
To amplify the signal and the potential value of pooling
synonymous UMLS terms (CUIs) we manually aggregated
individual synonyms into 66 individual buckets. For ex-
ample, the 14 unique terms representing “paresis” (such as
“facial paresis,” “hemiparesis (right),” “hemiparesis (left),”
and “limb paresis”) were aggregated into the single bucket
“paresis”. The potential attribute strength of each of the
buckets was measured by a Chi Squared comparison of
the frequency of the terms in MS patients and controls.
Of the original 66 buckets, 50 proved to have high attri-
bute strength and were used in the classification modeling
(see Table 2). Buckets were grouped to demonstrate the
broad range of signs and symptoms of MS as well as the
many related but specific categories of loss of function or
disability. For example, there are nine different but related
buckets of terms that reflect complications and involve-
ment of the motor system.
For classification, if a patient had a single mention of
any one of a particular bucket terms in any of their clinical
notes they were scored a 1 for that bucket (and a 0 if not).
Thus, for each of the MS and control patients, attribute
columns were filled according to the presence or absence
Fig. 1 Timing of clinical notes used in classification studies. For MS patients in the MS-enriched set, the notes used were written either before or
after the entry of first ICD9 code for MS (IDC9[MS]). For control patients in the MS-enriched set and the Random sample set, the notes used were
those entered within the last two years of the most recent note
Chase et al. BMC Medical Informatics and Decision Making  (2017) 17:24 Page 3 of 8
of any one of the several terms within a bucket. If a patient
had mention of a term on multiple dates or multiple
terms in a bucket, he or she would still receive only a 1
for the bucket.
Classification of patients known to have MS
The first step to developing the diagnostic assistant was
to determine if a classification approach using the ex-
tracted signs and symptoms of MS could be used to
identify the MS patients already known to have the dis-
ease. We developed an MS classification model using
the notes of patients with well-established MS (post-
ICD9[MS] notes of the MS-enriched set) and controls.
The classification model yielded an ROC AUC, sensitiv-
ity and specificity of 0.90 [0.87–0.93], 75% [66–82%],
and 91% [87–93%] respectively.
Classification of the Random sample set enabled us to
obtain a more accurate measurement of sensitivity and
specificity of classification of patients known to have MS
as well as the true prevalence of MS in our adult popula-
tion which would allow calculation of positive and nega-
tive predictive values [37, 38]. Classification of the
Random sample set, using the model described above,
yielded an ROC AUC, sensitivity and specificity of 0.94
[0.93 - 0.95], 81% [54–95%], and 87% [86–89%], respect-
ively. Based on the observed prevalence of MS in this
AIM population of 0.8% (Table 1), and the sensitivity and
specificity, the positive and negative predictive values were
3.8% (2.7–7.8%) and 0.15% (0.05–0.47%), respectively.
Classification of patients not known to have MS
We used the classification model, described above, to iden-
tify patients of the random sample who might have
Table 2 Buckets of MS-related UMLS terms used as attributes for
MS classification. For each bucket, the frequency of terms in MS
patients was compared to controls. The significance of the
difference was measured by Chi squared analysis (in parenthesis).
Buckets are grouped by common symptoms of loss of function
BUCKET SYMPTOM GROUP
1 Bladder dysfunction (115.8) Autonomic dysfunction
2 Constipation (22.4)
3 Memory (46.4) Cognition
4 Cognitive (19.4)




9 Dizziness (29.9) Dizziness and vertigo
10 Vertigo (17.2)
11 Diplopia (43.8) Eye and Vision
12 Nystagmus (48.6)
13 Optic neuritis (79.2)
14 Orbital pain (30.0)
15 Vision (88.9)
16 Fatigue (30.7) Fatigue
17 Weak (189.0)
18 Headache (65.8) Headache
19 Migraine (22.5)
20 Depression (24.2) Mood
21 Mood (36.5)
22 Pain-musculoskeletal (12.1) Pain
23 Pain-other (7.3)









33 Burning (20.0) Sensory
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44 Fall (57.3) Walking (gait)
45 Gait (79.2)
46 Walk (45.8)
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unrecognized MS. These patients would be amongst those
classified as having MS but lacking an ICD9[MS] code.
Classification identified 295 such patients, out of a total co-
hort of 2289. We manually reviewed the notes of a random
sample of 45 of these patients and identified four who
could have unrecognized MS. For example, one 74-year-old
woman complained of migraines, occipital neuralgia, had
an abnormal EMG, hand numbness and bowel incontin-
ence, all of which are important symptoms of MS. A sec-
ond patient, a 75-year old woman complained of peripheral
neuropathy, urinary incontinence and visual changes. The
remainder of the reviewed patients had one or more med-
ical conditions characterized by the signs and symptoms
listed in Table 2, such as cerebrovascular accident, diabetic
neuropathy, chronic migraine headaches, seizure disorders,
brain cancer, metastatic cancer to the brain and traumatic
brain injury. None of the four patients identified above as
potentially having MS had any of these neurological condi-
tions. However, inasmuch as none of the four patients sus-
pected to have MS had been seen by a neurologist and
were lacking additional follow-up, it was not possible to as-
certain whether or not these patients actually had MS.
We next focused on the cohort of patients who were
known to have MS (ICD9[MS]) and asked if the classifier
would identify these patients as having MS using the notes
entered before the initial entry of the ICD9[MS] code. Of
the 165 patients with MS in the MS-enriched cohort, 30
had notes in the EHR up to two years prior to the first
entry of an ICD9[MS] code. We trained a classifier using
the pre-ICD9[MS] set of these 30 patients of the MS-
enriched cohort (Fig. 1) and found that 40% of the patients,
with documented MS, were identified by classification
using notes entered before the initial ICD9[MS]. The
ROC AUC, sensitivity and specificity were 0.71 [0.66 –
0.76], 40% [23–59%] and 97% [93–98%], respectively.
We sought to determine the temporal relationship
between the dates of the first ICD9[MS] entry in the
pre-ICD9[MS] set of the MS-enriched cohort and the first
recognition of MS by a provider. We manually reviewed
the notes of these patients from the time the initial
ICD9 code was logged and back in time up to two years
before. The dates of the first mention of the illness by
the provider in a note and the dates of entry of an
ICD9[MS] code were the same in 75% (58–93%) of these
patients. Of the remaining patients, the dates of mention
of MS (or the possibility of a demyelinating disease) in
the notes was on average two months prior to the entry
of the first ICD9[MS] code.
Discussion
Using NLP to identify patients with MS early in the course
of the disease
The purpose of our study was to explore the possibility
that patients with MS could be identified earlier in the
course of their illness using classification of the signs
and symptoms in the clinical notes. Our results demon-
strate that earlier identification is feasible. First, we
found that 40% (23–59%) of the MS patients in the MS-
enriched set, with clinical notes entered into the EHR up
to two years prior to entry of the first ICD9[MS] code,
were classified as having MS. The concordance be-
tween the date of entry of an ICD9[MS] code and
first reporting of the illness by the provider in 75%
(58–93%) of the reviewed patients suggests that clas-
sification identified patients who have not yet been
recognized as having MS, not simply missing a timely
entry of an ICD9[MS] code. Second, manual review
of the patients in the Random sample set, those clas-
sified as has having MS but lacking an ICD9[MS]
code identified four of 45 patients’ whose clinical re-
cords suggested that they could have MS given that
they had signs and symptoms of MS and did not have
an obvious neurological condition that mimicked MS.
These observations suggest the feasibility of building
a diagnostic assistant to identify patients with MS
early in the course of their disease perhaps before
recognition by the primary provider.
Early diagnosis of a chronic illness through extraction
and analysis of clinical terms has been explored previ-
ously in studies of celiac disease, well-known to elude
diagnosis for years [39]. Two investigations achieved ex-
cellent results using different methods to classify patients
with celiac disease based on the signs and symptoms
present in the medical record [40, 41]. Neither study, how-
ever, determined if classification could identify patients
before the definitive diagnosis of the disease. A recent
study analyzed internet searching histories of patients with
pancreatic cancer to identify typical searches and search
terms before they knew that they had the illness [42].
They did not determine the sensitivity and specificity of
using those search terms in identifying patients with
pancreatic cancer.
Several groups have sought to identify patients with MS
using the data in the EHR, most notably the eMERGE ini-
tiatives, seeking to identify patients with various condi-
tions for genetic studies [43]. The eMERGE approach to
identify patients with MS used billing codes as well as
drugs used to treat MS and entry of “multiple sclerosis” in
the notes (using NLP). Davis and coworkers used ICD-9
codes, text keywords, and medications to identify patients
with MS and achieved excellent results [44]. Because our
long-term goal was to identify patients who might have
MS but had not yet been formally recognized as having
the illness we specifically avoided using ICD9[MS] codes,
drugs that treat MS, or the mention of MS in the notes as
attributes for the classifier. Using only signs and symp-
toms of MS and none of the above-mentioned MS-
specific attributes used in these other studies, our classifier
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achieved a comparable level of accuracy in identifying
patients already known to have MS.
Opportunity for EHR-based clinical decision support
Our results show that perhaps as many as 40% of MS pa-
tients could have been identified as having the illness from
the signs and symptoms in their notes, well in advance of
the initial recognition and assigning of an ICD9[MS] code.
The prevalence of MS is sufficiently low, 0.8% (or 1/125
patients) that a busy primary care provider, who first see
patients with MS [32], might not consider the illness. Inte-
grating a classification-based clinical decision support tool
has the potential to improve recognition of MS by provid-
ing a prompt to the provider early in the course of the
clinical encounter [45–47].
Any MS diagnostic support tool embedded the EHR,
however, would have to clearly communicate that the
machine was providing a suggestion, not making a diag-
nosis. Given our observation that, at best, 4/45 randomly
selected patients who were classified as MS but lacked
an ICD9[MS] could have MS, the post-test (post-classifi-
cation) probability would still only be in the neighbor-
hood of 10%. Thus, 90% of the “flagged patients,” those
classified as MS, would have some other neurologic con-
dition. Strategies to improve the post-test probability
could include removing patients with diseases known to
have signs and symptoms similar to MS, such as cere-
brovascular accident (CVA), diabetic neuropathy, or mi-
graines. While removing these patients would increase
specificity, it would also reduce the sensitivity of classifi-
cation lessening its utility as a diagnostic prompt given
that CVAs and migraines are common in patients with
MS [48, 49]. Thus, a post-test probability of 10% may be
the best that can be achieved using our approach. That
said, a probability of 10%, more than 10 times higher
than the prevalence of the disease in the general popula-
tion, justifies the prompt “consider MS.”
Limitations of the study
There are several important limitations of our study.
First, although there were a sufficient number of patients
with MS and notes after entry of the ICD9[MS] code to
train a classifier to identify patients with recognized MS,
there was an insufficient number who had notes entered
before the ICD9[MS] code to ascertain if classification
could identify them accurately before being recognized
as having the disease. Nor could we conclusively deter-
mine to what extent we could use the date of the initial
ICD9[MS] code as the date of recognition of the disease
by the provider. Thus, the classification sensitivity based
on the pre-ICD9[MS] notes is likely to be lower than the
observed 40%.” Clearly, a much larger set, probably
derived from data from several institutions, will be ne-
cessary to validate our findings. Second, patients in the
random sample whom we suspect may have MS, had
received no follow-up or referral to a neurologist (at the
time of writing) to ascertain whether or not they had
MS. We will have to follow these patients over the next
several years before knowing for certain. Third, the clas-
sifier was built and tested on our local patient popula-
tion which has a high proportion of Hispanic, largely
female elderly patients. Classification accuracy could be
different if applied to a largely white, younger population
given the known racial differences in the prevalence of
MS [50]. Fourth, we used MedLEE to parse the notes.
Many institutions have home-grown term-extractors
that would be used to replicate the classification ap-
proach described in this study. It is not known how well
these other NLP systems would perform [51]. Last, the
presence or absence of an ICD9[MS] code was used as
the gold standard for the presence of MS in both patient
sets. It is known that ICD coding for MS is inaccurate
meaning that a proportion of patients with MS will lack
an ICD9[MS] code while those who do not have MS re-
ceive an ICD9[MS] code [52]. Although this coding in-
accuracy influences the accuracy of the classification, it
is expected that the accuracy of the classification of
patients with known MS would be less than the true ac-
curacy. Thus, our estimates of specificity and sensitively
of classification of patients with known MS (ICD9[MS])
are likely an underestimate of the true values. We could
have used the eMERGE criteria to identify patients with
MS for the classification studies more accurately. How-
ever, given that our goal was to identify patients not
known to have MS by their providers, we chose not to
base the gold standard definition on the eMERGE cri-
teria which are derived from patients with known MS.
Conclusions
Diagnostic error, a common cause of medical error, might
be reduced with diagnostic assistants that recognize dis-
eases by mining patients’ clinical notes for signs and symp-
toms using NLP. We built a classifier, which identified
40% of patients with MS disease before formal documen-
tation of MS by providers suggesting that earlier recogni-
tion of the illness is possible. This approach could be
applied to other diseases often missed by primary care
providers such as cancer [45]. Whether implementing
diagnostic assistants based on this classification approach
ultimately shortens the time from earliest symptoms to
formal recognition of the disease remains to be seen and
will be the focus of future studies.
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